We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+36.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$3.01B
AUM Growth
+$583M
Cap. Flow
-$32.3M
Cap. Flow %
-1.07%
Top 10 Hldgs %
19.61%
Holding
374
New
40
Increased
94
Reduced
116
Closed
88

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$26.9M
2
EBC icon
Eastern Bankshares
EBC
+$24.9M
3
MAX icon
MediaAlpha
MAX
+$21.2M
4
HLI icon
Houlihan Lokey
HLI
+$19.7M
5
ALGM icon
Allegro MicroSystems
ALGM
+$18.9M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$43.8M
2
BLD
TopBuild
BLD
+$38.3M
3
TWST icon
Twist Bioscience
TWST
+$28.8M
4
QTS
QTS REALTY TRUST, INC.
QTS
+$25M
5
PS
Pluralsight, Inc. Class A Common Stock
PS
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 23.28%
2 Technology 20.52%
3 Consumer Discretionary 15.17%
4 Industrials 13.7%
5 Financials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLNX
176
DELISTED
Xilinx Inc
XLNX
$697K 0.02%
4,914
-3,283
-40% -$427K
PNFP icon
177
Pinnacle Financial Partners Inc
PNFP
$15.5B
$681K 0.02%
10,580
-81,988
-89% -$4.23M
TER icon
178
Teradyne
TER
$54.8B
$681K 0.02%
5,680
-179
-3% -$18.3K
ZEN
179
DELISTED
ZENDESK INC
ZEN
$662K 0.02%
4,622
-165
-3% -$20.5K
PEGA icon
180
Pegasystems
PEGA
$4.41B
$651K 0.02%
9,764
-360
-4% -$23K
RNG icon
181
RingCentral
RNG
$4.05B
$633K 0.02%
1,671
-51
-3% -$15.9K
FTV icon
182
Fortive
FTV
$19B
$632K 0.02%
11,839
-2,847
-19% -$146K
AMSC icon
183
American Superconductor
AMSC
$1.48B
$608K 0.02%
+25,948
New +$460K
MKTX icon
184
MarketAxess Holdings
MKTX
$4.15B
$608K 0.02%
1,066
-1,042
-49% -$568K
CPAY icon
185
Corpay
CPAY
$24.2B
$606K 0.02%
+2,221
New +$570K
ADI icon
186
Analog Devices
ADI
$181B
$595K 0.02%
4,030
-154
-4% -$20.4K
XLRN
187
DELISTED
Acceleron Pharma
XLRN
$595K 0.02%
4,653
+1,935
+71% +$227K
HOLX
188
DELISTED
Hologic
HOLX
$592K 0.02%
8,135
-308
-4% -$21.7K
MRNA icon
189
Moderna
MRNA
$21.5B
$560K 0.02%
5,356
-1,846
-26% -$187K
RPM icon
190
RPM International
RPM
$13.7B
$557K 0.02%
6,134
-225
-4% -$19.8K
ALNY icon
191
Alnylam Pharmaceuticals
ALNY
$36.3B
$555K 0.02%
4,269
-3,370
-44% -$450K
SPLK
192
DELISTED
Splunk Inc
SPLK
$548K 0.02%
3,223
-948
-23% -$181K
HD icon
193
Home Depot
HD
$332B
$535K 0.02%
2,015
-1,021
-34% -$281K
LITE icon
194
Lumentum
LITE
$59.4B
$524K 0.02%
5,531
+1,486
+37% +$128K
KEYS icon
195
Keysight
KEYS
$54.5B
$519K 0.02%
3,932
-141
-3% -$16.2K
TTWO icon
196
Take-Two Interactive
TTWO
$43B
$514K 0.02%
2,475
-2,781
-53% -$486K
APH icon
197
Amphenol
APH
$188B
$505K 0.02%
15,432
-496
-3% -$15.2K
ADBE icon
198
Adobe
ADBE
$89.5B
$496K 0.02%
992
-27
-3% -$13K
CHWY icon
199
Chewy
CHWY
$8.54B
$493K 0.02%
5,481
-206
-4% -$15K
BLD
200
DELISTED
TopBuild
BLD
$484K 0.02%
2,631
-216,475
-99% -$38.3M
6 7
8
9 10

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Emerald Advisers held 374 positions worth $3.01B, up 24% from $2.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q4 2020 filing shows 40 new, 94 increased, 116 reduced and 88 closed positions. Its largest new stake was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $43.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2020 buy was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M.
  • Emerald Advisers added most to Arena Pharmaceuticals Inc in Q4 2020, an estimated $18.6M increase.
  • Emerald Advisers's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $43.8M.
  • Emerald Advisers fully exited Pluralsight, Inc. Class A Common Stock in Q4 2020, selling an estimated $24.1M.
  • Emerald Advisers's ten largest holdings make up 20% of its $3.01B portfolio in Q4 2020.
  • Emerald Advisers opened 40 new positions and closed 88 in Q4 2020.
  • Emerald Advisers's portfolio value rose 24% quarter-over-quarter to $3.01B.

Based on Emerald Advisers's 13F filing for Q4 2020, filed 29 Jan 2021.